DLX4 and ovarian cancer: High expression of DLX4 is associated with reduced survival of ovarian cancer patients and found to stimulate attachment of ovarian tumor cells to peritoneal mesothelial cells in vitro and increase the numbers of peritoneal implants in xenograft models [73].